SEELOS THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.9 USD | -18.80% |
|
-11.38% | -82.91% |
| May. 14 | Seelos Therapeutics to Implement Reverse Stock Split to Regain Bourse Compliance | MT |
| May. 14 | Seelos Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Seelos Therapeutics, Inc.
4e10f05167192e4b5.UHKLz3UMJoeNlcmi2ahakYuonzJ3JAHxfdlHkH9a3MU.GhTahyNIUsC71rHko80P_93DxgIkbWmpFr4z0wVvufIFI8qeTDhj6N_CjA~d74d3c467ef26ea7f1250f70c9103cca
Upcoming events on Seelos Therapeutics, Inc.
Past events on Seelos Therapeutics, Inc.
| 2024-04-25 | Q1 2024 Earnings Release (Projected) |
| 2024-01-10 08:00 am | Extraordinary Shareholders Meeting |
| 2023-11-13 09:00 am | Society for Neuroscience Meeting |
| 2023-09-20 08:00 am | SLS-002 Phase II Study Results Call |
| 2023-08-13 | Q2 2023 Earnings Release |
| 2023-07-18 01:00 pm | Investor Meeting - Key Opinion Leader |
| 2023-05-19 03:00 pm | American Society of Gene and Cell Therapy Meeting |
| 2023-05-17 | Annual General Meeting |
| 2023-05-15 08:00 am | Q1 2023 Earnings Release |
| 2023-03-05 | Cowen Health Care Conference |
| 2023-02-22 08:00 pm | Alzheimer & Parkinson Drug Development Summit |
| 2023-01-08 | LifeSci Partners Corporate Access Conference |
| 2022-12-15 01:00 pm | Business Update Call |
| 2022-11-15 01:35 pm | Guggenheim Immunology and Neurology Conference |
| 2022-11-03 05:45 pm | Ataxia Research International Congress |
| 2022-10-05 | Cantor Neurology & Psychiatry Conference |
| 2022-09-28 02:45 pm | Guggenheim Therapeutics Conference |
| 2022-09-21 | Jefferies Innovation in Mental Health Summit |
| 2022-06-10 11:30 am | Jefferies Healthcare Conference |
| 2022-05-20 08:00 am | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,38 0,40 -6.25% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 2,20 1,55 42.13% |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -29,7 -23,9 -24.29% | -18,8 -17,2 -8.93% | -61,7 -45,1 -36.76% | -70,9 -68,6 -3.33% | -40,5 -39,5 -2.56% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -51,3 -45,0 -13.84% | -19,1 -16,9 -12.83% | -66,0 -49,6 -33.16% | -73,5 -70,2 -4.71% | -37,9 -39,4 3.9% |
|
Net income Million USD | Released Forecast Spread | -51,3 -45,0 -13.84% | -19,1 -16,9 -12.83% | -66,0 -49,6 -33.16% | -73,5 -70,2 -4.71% | -37,9 -39,4 3.9% |
|
EPS USD | Released Forecast Spread | -605 -791 23.52% | -103 -91,2 -13.16% | -175 -132 -32.33% | -166 -151 -9.52% | -61,8 -3,28 -1785.37% |
| Announcement Date | 17/03/20 | 11/03/21 | 04/03/22 | 10/03/23 | 06/03/24 |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,81 0,00 - | 0,34 0,00 - | 0,41 0,00 - | 0,65 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -14,0 -18,7 25.27% | -21,2 -15,4 -37.67% | -17,4 -12,5 -39.5% | -18,3 -16,0 -14.44% | -8,93 -13,3 32.81% | -11,0 -10,2 -7.09% | -12,6 -11,5 -9.22% | -8,01 -7,00 -14.44% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,0 -18,7 25.1% | -21,3 -15,4 -37.93% | -19,6 -12,5 -57.14% | -18,7 -16,0 -16.89% | -13,4 -13,2 -1.72% | -29,5 -10,3 -187.65% | 10,5 -11,5 191.12% | -5,45 -6,99 22.01% |
|
Net income Million USD | Released Forecast Spread | -14,0 -18,7 25.1% | -21,3 -15,4 -37.93% | -19,6 -12,5 -57.14% | -18,7 -16,0 -16.89% | -13,4 -13,2 -1.72% | -29,5 -10,3 -187.65% | 10,5 -11,5 191.12% | -5,45 -6,99 22.01% |
|
EPS USD | Released Forecast Spread | -31,2 -43,2 27.78% | -48,0 -34,4 -39.53% | -43,2 -27,2 -58.82% | -40,8 -31,2 -30.77% | -28,8 -25,6 -12.5% | -52,8 -22,8 -131.58% | 19,2 -14,4 233.33% | -6,40 |
| Announcement Date | 10/05/22 | 05/08/22 | 10/11/22 | 10/03/23 | 12/05/23 | 11/08/23 | 14/11/23 | 06/03/24 |
More events
Past sector events for Seelos Therapeutics, Inc.
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-15 04:01 pm | CELCUITY INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SEEL Stock
- Calendar Seelos Therapeutics, Inc.
